Berry Genomics' continuous share price and revenue decline s...

Berry Genomics' continuous share price and revenue decline signals the risk of investing in unprofitable firms. Last year's performance suggests unresolved challenges. Investors should consider these risks and ensure they invest in high-quality businesses.